HOUSTON, TX, August 20, 2026 /24-7PressRelease/ -- Ruba Sarris Sawaya has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mrs. Sawaya's career is distinguished less by any single title than by its reach. For more than 25 years she has worked with device companies, investors and public-sector government organizations to move new technologies from concept into clinical use, integrating regulatory, clinical, reimbursement and commercialization strategy into a single discipline rather than four sequential handoffs. In 2021 she built that discipline into a firm, MediStrat360, where she serves as chief executive officer and managing partner. Since 2025 she has also served as chief operating officer of Otricath NHC LLC, an interventional oncology company whose delivery platform is designed to concentrate therapy at the tumor site and recover residual drug, with the potential to improve efficacy while reducing systemic toxicity.

Since 2018, Mrs. Sawaya also serves as an executive advisor to the Texas Medical Center Innovation Factory, leading workshops for device-focused cohorts on clinical research, regulatory strategy, reimbursement and market access. Her counsel has been sought after from companies across the sector. She was fractional chief commercialization officer at RizLab Health Inc. in 2024; interim head of quality, regulatory and clinical affairs at Alertgy from 2023 to 2024; fractional chief scientific officer at TYBR Health; and chief executive advisor for quality, regulatory and clinical affairs at Molecular Testing Labs from 2022 to 2023.

Her principal corporate roles spanned twenty years before the consulting practice began, and include an appointment as the executive vice president of clinical affairs at DJO Global, now Enovis. Before that she advanced through a series of leadership positions at Medtronic, working across strategy, business development, clinical research and market access within the company's Enabling Technologies, Surgical Technologies and Spine divisions.

Mrs. Sawaya regards her tenure at Orthofix Medical Inc. as the pivot of her career. She arrived to run preclinical research, expanded into clinical research, and then made the case internally for an infrastructure that widened clinical affairs into GCORE- encompassing clinical research, health economics outcomes research, reimbursement and government affairs. That expanded remit produced the achievement she names as her proudest. When shifts in Medicare coverage policy threatened patient access to bone growth stimulators, Mrs. Sawaya spent nearly two years working with a coalition to build the clinical and economic case for continued coverage and advocating for patients on Capitol Hill. The classification held, and with it access for every patient who needed the device in the years that followed.

Colleagues credit her with a rare combination: she is steady in a regulatory crisis, and better still at building a solid strategy that prevents one. She approaches device commercialization as a single system - user needs, regulation, evidence, reimbursement and public policy - and holds fast to her belief that effective strategic foresight enables devices that can not only survive regulatory scrunity, but that are built to be covered, adopted and used. She is a member of Chief, the organization for executive women, a former member of the North American Spine Society, and has served on AdvaMed's Orthopedic Sector Coalition representing DJO.

Academically, Mrs. Sawaya earned a Master of Public Health with a concentration in epidemiology from UTHealth Houston in 2014, completing the degree while holding a director-level position with Orthofix leading clinical trials globally. She received a bachelor's degree in biology, with triple minors in chemistry, physics and English, from Austin College in Sherman, Texas, in 2003, and completed the Executive Management Program through the Posey Leadership Institute.

Asked to account for her career, Mrs. Sawaya points first to her parents, who treated family, education and hard work as non-negotiables. She also credits the mentors who offered candid feedback at moments when it would have been easier to offer none. And she credits an uncle, a cardiologist who measured his practice not by what it earned, but by what it gave away to charities worldwide.

What she received from mentors she has spent a decade handing forward. Mrs. Sawaya advises over a dozen women in medtech, meeting them quarterly to work through the questions careers turn on: what to advocate for, when to walk, how to be heard in rooms not built for them, and how to stop apologizing for the room they earned. She counts it among her most meaningful accomplishments.

Born in Amman, Jordan, Mrs. Sawaya immigrated to the United States at 12 with limited English. She worked multiple jobs through high school before earning a scholarship to Austin College and a place in the Posey Leadership Institute. Two decades later she was the youngest member of DJO's C-suite.

Looking ahead, she is weighing ambitions of a different order: clean water in developing countries, medtech careers introduced to high school students who have never heard the field named, a wider path for women in medical technology, and government initiatives capable of transforming public health for communities at scale. The measure of Mrs. Sawaya's career has never been the return, but the impact: more than 1,000 devices, an estimated 100 million people, and the conviction that neither figure is final.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. The suite of Marquis® publications, including Who's Who in America® and Who's Who in the World®, remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the globe. Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #